Newsletter Signup | Join Community
The BEACON clinical trial defines new treatment for BRAF V600E - mutant advanced colorectal cancer
Genomic testing identifies genetic targets that can be treated with precision cancer medicines avoiding chemotherapy
TAPUR study identifies BRAF V600 as target in colorectal cancer, additional study enrollment ongoing
Understand treatment options for recurrent colon cancer: the role of genomic testing and clinical trials.
Most stage I colon cancers are treated with surgery alone but some individuals may require additional therapy.
Surgery, chemotherapy, biomarker testing and precision cancer medicines all part of stage III colon cancer treatment.
Updates on screening, treatment advances and prevention of Colon and Rectal Cancer.
Did your doctor do an OncotypeDX colon cancer test? Curious how many people with stage II or III…
What have you found that helps with neuropathy?…
Has anyone's oncologist recommended "shorter duration" chemotherapy for stage 2 or 3 colon cancer to…
How many people take an Aspirin a day?
Duke study suggest same bacteria that cause gastric cancer may be associated with colon cancer:…
Bisphosphonates May Reduce Risk of Colorectal Cancer